Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Antimicrobial Agents|November 10, 2019
Meropenem-nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection modelTomefa E Asempa, Ana Motos, Kamilia Abdelraouf, et al.
European Journal of Medicinal Chemistry|July 9, 2004
Syntheses and GABA uptake properties of 6-ether- and 6-enol ether-substituted nipecotic acidsVictor N'Goka, Caterina Bissantz, Philippe Bisel, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing <i>Enterobacteriaceae</i> in the Neutropenic Murine Lung Infection ModelTomefa E Asempa, Ana Motos, Kamilia Abdelraouf, et al.
International Journal of Antimicrobial Agents|May 2, 2024
Impact of nutritional factors on in vitro PK/PD modelling of polymyxin B against various strains of Acinetobacter baumanniiMathilde Lacroix, Jérémy Moreau, Claudia Zampaloni, et al.
Antibiotics (Basel, Switzerland)|January 22, 2024
Translational PK/PD for the Development of Novel Antibiotics-A Drug Developer's PerspectiveCaterina Bissantz, Claudia Zampaloni, Pascale David-Pierson, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2025
<i>In vitro</i> pharmacokinetic/pharmacodynamic modeling of the effect of mucin on polymyxin B activity against <i>Acinetobacter baumannii</i>Mathilde Lacroix, Jérémy Moreau, Claudia Zampaloni, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2019
A novel mechanism-based pharmacokinetic-pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteriaAnders N Kristoffersson, Caterina Bissantz, Rusudan Okujava, et al.
Journal of Medicinal Chemistry|October 13, 2009
Identification of a critical residue in the transmembrane domain 2 of tachykinin neurokinin 3 receptor affecting the dissociation kinetics and antagonism mode of osanetant (SR 142801) and piperidine-based structuresPari Malherbe, Claudia Kratzeisen, Anne Marcuz, et al.
Journal of Medicinal Chemistry|July 25, 2020
Stepwise Design of γ-Secretase Modulators with an Advanced Profile by Judicious Coordinated Structural Replacements and an Unconventional Phenyl Ring BioisostereRosa María Rodríguez Sarmiento, Caterina Bissantz, Johan Bylund, et al.
Molecular Pharmacology|March 1, 2008
Me-talnetant and osanetant interact within overlapping but not identical binding pockets in the human tachykinin neurokinin 3 receptor transmembrane domainsPari Malherbe, Caterina Bissantz, Anne Marcuz, et al.
Pageof 4